What did PHC Holdings Corporation pay for Thermo Fisher Anatomical Pathology Business?

PHC Holdings Corporation acquired Thermo Fisher Anatomical Pathology Business for $1.14B in 2019, equivalent to 3.30x revenue. Target revenue was approximately $350.0M.

What does Thermo Fisher Anatomical Pathology Business do?

Thermo Fisher Anatomical Pathology Business is a laboratory services business.

What multiple did PHC Holdings Corporation pay for Thermo Fisher Anatomical Pathology Business?

3.30x revenue, based on disclosed deal value of $1.14B and disclosed financials.

M&A TRANSACTION · 2019

Thermo Fisher Anatomical Pathology Business acquired by PHC Holdings Corporation

$1.14B· 3.30x revenue

Target

Thermo Fisher Anatomical Pathology Business

Acquirer

PHC Holdings Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$350.0M

EBITDA

—

Deal Value

$1.14B

EV/EBITDA

—

Context

This $1.14B acquisition of Thermo Fisher Anatomical Pathology Business by PHC Holdings Corporation sits in the laboratory services sub-vertical. PHC Holdings Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Thermo Fisher Anatomical Pathology Business acquisition.

Citation: ExitValue.ai. (2019). Thermo Fisher Anatomical Pathology Business acquired by PHC Holdings Corporation. https://exitvalue.ai/deals/thermo-fisher-anatomical-pathology-business-acquired-by-phc-holdings-corporation-hc-2019-0146